Linda Powers is the managing director and co-founder of Toucan Capital Corp, a $120 million venture capital fund (SBIC) focused on seed and early-stage life science and advanced technology investments (the fund markets itself as the The Leading US Investor in Stem Cells and Regenerative Medicine). Out of here insights and facts presented on the… Continue reading SENS3: The stem cell marketplace by Linda Powers, Tucan Capital (slides)
In the age of compelling technology analogies and nomenclatures it was unavoidable that somebody at last identifies enough differences in the history of industrial regenerative medicine to tell Regenerative Medicine 1.0 from 2.0. The man behind is Chris Mason, Group Leader of Stem Cell + Regenerative Medicine Bioprocessing Unit, University College London and cofounder and… Continue reading Are we really in the age of Regenerative Medicine 2.0? A comparison by Chris Mason
Check out Business 2.0’s 100 fastest growing tech companies and read the excellent little summaries on the first 25 out of which 5 are medical related. In regenerative medicine LifeCell has a high position with competitors like Genentech (here think about the recent 23andMe story), Amgen Inc, Gilead Sciences.
Business 2.0 Blog Beta Network‘s new blog BioTech(nically) was launched written by Marie Cannizzaro who says about herself in the intro post, March 27: “Before joining Business 2.0, I wrote for Dow Jones VentureWire and Stanford Magazine. I have a degree in Human Biology with a concentration in Biotechnology and Bioethics from Stanford University.” At… Continue reading BioTech(nically), Business 2.0’s new biotech blog
Research and Markets has announced the addition of Regenerative Medicine – Global Strategic Business Report to their offering for EUR 3,407.00. Link “This report analyzes the worldwide markets for Regenerative Medicine in Millions of US$. The report provides separate comprehensive analytics for the US, Japan, Europe, Canada, and Asia-Pacific, and Rest of World. Annual forecasts… Continue reading Technological breakthroughs in Regmed according to a Global Strategic Business Report
Well, I am pleased to announce that we’ve just entered into an era of online scientific video sharing as there exists now a nascent niche market around. After the first mover JoVE (Journal of Visualized Expermients, covered many times here), LabAction.com was launched on 21st March 07 with as many as 3 biology-related videos. And… Continue reading LabAction.com: new player on the science video niche market
The recent Carnival of Biotechnology is hosted on Babybiotechs and is rather industry and business oriented which is a good sign of a more mature industry. Check the posts and form an opinion.